Overview

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

Status:
Recruiting

Trial end date:
2024-03-31

Target enrollment:

Participant gender:

Summary

The purpose of the trial is to verify the effectiveness and safety of glimepiride compared with sitagliptin as an add-on therapy to metformin in severe insulin deficiency diabetes.

Phase:

Phase 4

Details

Lead Sponsor:

Peking University People's Hospital

Collaborators:

Jiangsu Province Geriatric Institute
Peking University First Hospital

Treatments:

Dipeptidyl-Peptidase IV Inhibitors
Glimepiride
Sitagliptin Phosphate